Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accounts Payables (2016 - 2017)

Historic Accounts Payables for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $579386.0.

  • Tenax Therapeutics' Accounts Payables fell 5839.46% to $579386.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $579386.0, marking a year-over-year decrease of 5839.46%. This contributed to the annual value of $727599.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Accounts Payables is $579386.0, which was down 5839.46% from $434195.0 recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Accounts Payables peaked at $1.5 million during Q2 2016, and registered a low of $434195.0 during Q2 2017.
  • Over the past 4 years, Tenax Therapeutics' median Accounts Payables value was $972483.0 (recorded in 2015), while the average stood at $979723.0.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 8001.95% in 2013, then tumbled by 7146.22% in 2017.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Accounts Payables stood at $977162.0 in 2013, then fell by 0.48% to $972483.0 in 2015, then dropped by 25.18% to $727599.0 in 2016, then fell by 20.37% to $579386.0 in 2017.
  • Its last three reported values are $579386.0 in Q3 2017, $434195.0 for Q2 2017, and $1.4 million during Q1 2017.